Abstract
BackgroundSeveral studies have shown that disease activity-guided dose reduction without deterioration of disease activity is possible, while saving costs in patients with stable and low disease activity.(1 Despite these positive...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
